期刊文献+

Rho kinase:A new target for treatment of cerebral ischemia/reperfusion injury 被引量:7

Rho kinase: A new target for treatment of cerebral ischemia/reperfusion injury
下载PDF
导出
摘要 Rho kinase inhibitor fasudil hydrochloride has been shown to reduce cerebral vasospasm, to inhibit inflammation and apoptosis and to promote the recovery of neurological function. However, the effect of fasudil hydrochloride on claudin-5 protein expression has not been reported after cerebral ischemia/reperfusion. Therefore, this study sought to explore the effects of fasudil hydrochloride on blood-brain barrier permeability, growth-associated protein-43 and claudin-5 protein expression, and to further understand the neuroprotective effect of fasudil hydrochloride. A focal cerebral ischemia/reperfusion model was established using the intraluminal suture technique. Fasudil hydrochloride (15 mg/kg) was intraperitoneally injected once a day. Neurological deficit was evaluated using Longa's method. Changes in permeability of blood-brain barrier were measured using Evans blue. Changes in RhoA, growth-associated protein-43 and claudin-5 protein expression were detected using immunohistochemistry and western blotting. Results revealed that fasudil hydrochloride noticeably contributed to the recovery of neurological function, improved the function of blood-brain barrier, inhibited RhoA protein expression, and upregulated growth-associated protein-43 and claudin-5 protein expression following cerebral ischemia/reperfusion. Results indicated that Rho kinase exhibits a certain effect on neurovascular damage following cerebral ischemia/reperfusion. Intervention targeted Rho kinase might be a new therapeutic target in the treatment of cerebral ischemia/reperfusion. Rho kinase inhibitor fasudil hydrochloride has been shown to reduce cerebral vasospasm, to inhibit inflammation and apoptosis and to promote the recovery of neurological function. However, the effect of fasudil hydrochloride on claudin-5 protein expression has not been reported after cerebral ischemia/reperfusion. Therefore, this study sought to explore the effects of fasudil hydrochloride on blood-brain barrier permeability, growth-associated protein-43 and claudin-5 protein expression, and to further understand the neuroprotective effect of fasudil hydrochloride. A focal cerebral ischemia/reperfusion model was established using the intraluminal suture technique. Fasudil hydrochloride (15 mg/kg) was intraperitoneally injected once a day. Neurological deficit was evaluated using Longa's method. Changes in permeability of blood-brain barrier were measured using Evans blue. Changes in RhoA, growth-associated protein-43 and claudin-5 protein expression were detected using immunohistochemistry and western blotting. Results revealed that fasudil hydrochloride noticeably contributed to the recovery of neurological function, improved the function of blood-brain barrier, inhibited RhoA protein expression, and upregulated growth-associated protein-43 and claudin-5 protein expression following cerebral ischemia/reperfusion. Results indicated that Rho kinase exhibits a certain effect on neurovascular damage following cerebral ischemia/reperfusion. Intervention targeted Rho kinase might be a new therapeutic target in the treatment of cerebral ischemia/reperfusion.
出处 《Neural Regeneration Research》 SCIE CAS CSCD 2013年第13期1180-1189,共10页 中国神经再生研究(英文版)
基金 funded by the National Natural Science Foundation of China,No.30870855 the Natural Science Foundation of Beijing,No.7082028 Beijing Municipal Health System High-Level Technician Cultivation Project,No.2009-3-07
关键词 neural regeneration brain injury cerebral ischemia Rho kinase fasudil hydrochloride RHOA growth-associated protein-43 CLAUDIN-5 neurovascular unit blood-brain barrier grants-supportedpaper NEUROREGENERATION neural regeneration brain injury cerebral ischemia Rho kinase fasudil hydrochloride RhoA growth-associated protein-43 claudin-5 neurovascular unit blood-brain barrier grants-supportedpaper neuroregeneration
  • 相关文献

参考文献1

二级参考文献71

  • 1Kubo T,Hata K,Yamaguchi A,et al.Rho-ROCK inhibitors as emerging strategies to promote nerve regenerationCurrent Pharmaceutical Design,2007.
  • 2Schweigreiter,R,Walmsley,AR,Niederost,B,Zimmermann,DR,Oertle,T,Casademunt,E,Frentzel,S,Dechant,G,Mir,A,Bandtlow,CE.Versican V2 and the central inhibitory domain of Nogo-A inhibit neurite growth via p75NTR/NgR-independent pathways that converge at RhoAMolecular and Cellular Neurosciences,2004.
  • 3Fournier AE,Takizawa BT,Strittmatter SM.Rho kinase inhibition enhances axonal regeneration in the injured CNS. Journal de Neuroradiologie . 2003
  • 4Dergham P,Ellezam B,Essagian C,et al.Rho signaling pathway targeted to promote spinal cord repair. Journal of Neuroscience, The . 2002
  • 5Emilie Pacary,Emmanuelle Tixier,Florence Coulet ,et al.Crosstalk between HIF-1 and ROCK pathways in neuronal differentiation of mesenchymal stem cells, neurospheres and in PC12 neurite outgrowth. Molecular and Cellular Neuroscience . 2007
  • 6Raquel Rodrigues-Díez,Gisselle Carvajal-González,Elsa Sánchez-López,Juan Rodríguez-Vita,Raúl Rodrigues Díez,Rafael Selgas,Alberto Ortiz,Jesús Egido,Sergio Mezzano,Marta Ruiz-Ortega.Pharmacological Modulation of Epithelial Mesenchymal Transition Caused by Angiotensin II. Role of ROCK and MAPK Pathways[J]. Pharmaceutical Research . 2008 (10)
  • 7Zhiqun Zhang,Andrew K. Ottens,Stephen F. Larner,Firas H. Kobeissy,Melissa L. Williams,Ronald L. Hayes,Kevin K. W. Wang.Direct Rho-associated kinase inhibiton induces cofilin dephosphorylation and neurite outgrowth in PC-12 cells[J]. Cellular & Molecular Biology Letters . 2006 (1)
  • 8Ijaz Ahmed,Yolanda Calle,Shintaro Iwashita,Alam Nur-E-Kamal.Role of Cdc42 in neurite outgrowth of PC12 cells and cerebellar granule neurons[J]. Molecular and Cellular Biochemistry . 2006 (1-2)
  • 9Nina Wettschureck,Stefan Offermanns.Rho/Rho-kinase mediated signaling in physiology and pathophysiology[J]. Journal of Molecular Medicine . 2002 (10)
  • 10Laishram J,,Avossa D,Shahapure R,Torre V.Mechanical computation in neurons. Dev Neurobiol . 2009

共引文献31

同被引文献41

引证文献7

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部